Evidence map›Paper›PMID 22668595›Full record

ReviewThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2012

Scale-up of isoniazid preventive therapy in PEPFAR-assisted clinical sites in South Africa.

C C Bristow, E Larson, A K Vilakazi-Nhlapo, M Wilson, J D Klausner

Abstract readReview
PubMed Publisher
In one paragraph

Review in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Short-course untargeted isoniazid preventive therapy in South Africa: time to rethink policy?The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2012
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

C C BristowUS Centers for Disease Control and Prevention South Africa, Pretoria, South Africa. BristowC@sa.cdc.gov
E Larson
A K Vilakazi-Nhlapo
M Wilson
J D Klausner

Funding

PEPFAR
6 · The paper itself

Abstract

We reviewed the implementation of isoniazid preventive therapy (IPT) in South Africa from January 2010 to March 2011. The South African National Department of Health distributed revised IPT guidelines in May 2010 to increase IPT use in eligible human immunodeficiency virus (HIV) infected patients. We found a dramatic increase in the absolute numbers of patients reported to have been initiated on IPT (from 3309 in January-March 2010 to 49 130 in January-March 2011), representing an increase in the proportion (1.0-10.5%) of potentially eligible HIV-infected patients started on IPT.

Indexed as

National Health ProgramsAntitubercular AgentsCommunicable Disease ControlEpidemicsGuideline AdherenceHIV InfectionsHumansInternational CooperationIsoniazidPractice Guidelines as TopicPractice Patterns, Physicians'Program EvaluationSouth AfricaTime FactorsTreatment OutcomeTuberculosisAntitubercular AgentsIsoniazid

Identifiers

PMID22668595

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.